This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Europe's premier partnering event
November 4–6, 2024 | Stockholm, SwedenNovember 12–13, 2024 | Digital Partnering

ZTI Biosciences


Zero To 1(one), ZTI stands for developing new technologies that were never before. ZTI BIOSCIENCES, combining its very own original platform nanotechnology with biotech, is developing a next generation therapeutic radiopharmaceuticals for intractable & recurring solid cancers. ZTI, with the Nano Platform tech TERACARRIERTM, will bring a new paradigm of cancer care, unearthing the full potential of radioisotopes, standardizing radiopharmaceuticals, and providing innovative solutions for various indications in the area of intractable oncology.